Skip to content
    CVSA
    Earnings call· Jun 2026(Q4 FY26)

    Covista Q4 FY26 earnings call CVSA

    Aug 6, 2026 Source

    Executive summary

    Covista Q4 FY26 — Exceeds Targets, Launches "Purpose at Scale" Strategy

    Covista successfully concluded its "Growth with Purpose" strategy, surpassing long-term financial targets through sustained enrollment growth and margin expansion. The company is now embarking on its "Purpose at Scale" strategy, focusing on platform extension, employer integration, and technology to address the structural demand in healthcare workforce education. This new phase is supported by a robust balance sheet and a commitment to continued capital returns.

    Highlights

    5
    • Full-year revenue grew 9.3% to $1.95 billion, exceeding the high end of raised guidance.

    • Full-year adjusted EPS grew 23.7% to $8.25, exceeding the high end of raised guidance.

    • Achieved 12 consecutive quarters of total enrollment growth across the company.

    • Full-year free cash flow of $393 million, representing a 39% increase year-over-year.

    • Net leverage improved to 0.5x, down from 0.8x at the end of fiscal 2025.

    Concerns

    2
    • Walden's academic calendar shift will result in one less week in Q2 FY27 and one additional week in Q3 FY27, impacting year-over-year comparisons in those quarters.

    • A higher effective tax rate is anticipated for fiscal 2027 compared to fiscal 2026.

    Guidance & targets

    6
    CategoryTargetConfidence
    Full-year Revenue
    $2,050 million to $2,090 million
    high materiality
    High
    Full-year Adjusted EPS
    $8.90 to $9.15
    high materiality
    High
    Full-year Adjusted EBITDA Margin Expansion
    approximately 0 to 50 basis points
    medium materiality
    Medium
    Chamberlain Total Enrollment Growth Rate
    accelerate again
    medium materiality
    High
    Capital Expenditure Run Rate
    slightly higher than the annualized fourth quarter fiscal 2026 spend
    low materiality
    Medium
    Effective Tax Rate
    higher
    low materiality
    High

    Segment performance

    3
    SegmentRevenueYoYQoQMargin
    Chamberlain
    Fourth quarter revenue increased, driven by pre-licensure nursing and masters program enrollment growth, along with pricing optimization. This marks the second consecutive quarter of positive total enrollment growth. Adjusted EBITDA margin expanded 20 basis points.
    Total enrollment growth: 1.6%Pre-licensure BSN total enrollment growth: 16th consecutive quarter
    $190.2 million3.2%24.6%
    Walden
    Fourth quarter revenue increased significantly, driven by strong enrollment growth. Total student enrollment reached its highest level in Walden's history, with strength across both health care and non-health care programs. Adjusted EBITDA margin expanded 410 basis points due to strong revenue growth and operational efficiencies.
    Total student enrollment: 55,000Total student enrollment growth: 14%Double-digit enrollment growth: 9th straight quarter
    $210.8 million15.7%33%
    Med/Vet
    Fourth quarter revenue increased, with total student enrollment growing, led by medical programs and accelerating new enrollment in both Med and Vet. Adjusted EBITDA margin expanded 30 basis points. Some Q4 enrollments reflect students moving ahead of OB3 loan changes, but the full-year trajectory is embedded in the FY27 guide.
    Total student enrollment: 5,100Total student enrollment growth: 7.3%
    $100.3 million10.7%22.4%

    Operational metrics

    16
    Net leverage
    0.5xdown from 0.8x at end of FY25
    Q4 FY26

    Improved due to robust cash generation and disciplined capital deployment.

    Shares outstanding reduction
    20%
    Over 3 years

    Achieved through returning meaningful capital to shareholders.

    Share repurchases
    $238 million
    FY26

    Part of the $750 million repurchase program authorized in late 2025.

    Remaining share repurchase authorization
    $662 million
    As of Q4 FY26

    Under the $750 million repurchase program.

    Interest expense
    $45.4 milliondeclined from $52.3 million
    FY26

    Reflecting actions to reduce and refinance debt and lower borrowing costs.

    Average diluted shares outstanding
    35.7 millionapproximately 2.6 million lower
    FY26

    Reflecting fiscal 2026 share repurchases.

    AI credentials enrollment
    9,000+
    As of Q4 FY26

    Launched in Q3 FY26, with additional certifications added in Q4 FY26.

    New programs launched
    1,700
    2026 academic year

    Added by new programs launched into the 2026 academic year.

    New programs launched
    4
    Last month

    Additional programs launched recently.

    Behavioral sciences programs
    2
    Ongoing

    Currently in regulatory review.

    New campuses in active development
    6
    Ongoing

    Part of platform extension strategy.

    New campuses with full regulatory approval
    3
    Ongoing

    Cincinnati and Salt Lake opening in H1 FY27.

    New campus capital cost
    $9 million to $12 million
    Per campus

    Attractive economics driving pace of development.

    New campus EBITDA breakeven
    24 months
    Post-opening

    Expected for new campuses, with steady-state margins accretive to existing base.

    Clinicians and healthcare executives reporting staffing shortages
    70%
    Current

    Indicates staffing shortages are affecting ability to deliver quality care.

    Healthcare executives investing meaningfully in talent partnerships
    22%
    Current

    Highlights a significant opportunity gap for Covista's employer integration strategy.

    Industry KPIs

    5
    MetricValueDetails
    EPS$8.25per share
    Revenue$1,954 millionUSD
    Net income$294.7 millionUSD
    Adjusted EBITDA ebita$521.7 millionUSD
    Share buyback capital return$238 millionUSD

    Product announcements

    3
    ProductTypeDetails
    AI credentials with Google Cloudexpansion
    AI-powered classroomroadmap
    New Walden programslaunch

    Deals & partnerships

    2
    SSMEmployer partnership for nursing education

    Early results with SSM are strong enough that Covista is expanding its target enrollment there, indicating successful collaboration in meeting nursing pipeline needs.

    Advocate HealthNew collaboration for nursing education

    A new collaboration with Advocate Health, the third-largest nonprofit integrated health system, to support building a sustainable nursing workforce. The program, delivered through Chamberlain, funds nursing education, builds clinical readiness, and creates a financially supported pathway into the profession. The first cohort starts in September.

    Risks & headwinds

    4
    Walden academic calendar shiftQ2 and Q3 FY27

    1 less week in Q2 FY27, 1 additional week in Q3 FY27

    Mitigation: No net impact for the full year comparison of fiscal 2027 to fiscal 2026.

    Higher effective tax rateFY27

    higher in fiscal 2027 than in fiscal 2026

    Stronger comparables for Walden and Med/VetFY27

    stronger comparables

    Mitigation: Already contemplated in long-term targets.

    Elevated investment levelsH1 FY27

    higher investment levels

    Mitigation: Expected adjusted EBITDA margin improvement to be in the back half of the year.

    What to watch in Q1 FY27

    5

    Chamberlain total enrollment growth rate

    Q1 FY27
    Current1.6% in Q4 FY26
    Targetaccelerate again

    Why it matters

    Chamberlain's enrollment trajectory is a key indicator of the success of platform extension initiatives and overall growth momentum.

    For the first quarter, we expect the total enrollment growth rate to accelerate again, consistent with the sequential improvement we saw from the third quarter to the fourth in fiscal 2026.

    Q&A highlights

    5

    What has been the impact of the OB3 loan changes, particularly after the July 1st deadline, on enrollment and student behavior?

    Management does not anticipate headwinds from OB3 changes. They observed some pull-forward activity in Med/Vet enrollments in Q4 FY26, viewing it as a consumer behavior dynamic that shortened the sales cycle for some students. This is seen as a net positive, creating capacity for future demand.

    We view that as a consumer behavior dynamic, not a shift in underlying demand, and the way we encourage investors to think about it is that a portion of the incremental growth coming in the fourth quarter as a shift between 2 periods, right?

    asked by Jack Slevin · answered by Stephen Beard

    2 min read6 chapters

    Detailed Narrative

    01

    "Growth with Purpose" Strategy Success

    Covista successfully completed its 3-year "Growth with Purpose" strategy, exceeding long-term targets set at its outset. This included growing revenue from less than $1.5 billion to $1.95 billion, expanding EBITDA margins by 300 basis points, nearly doubling adjusted EPS, and more than doubling free cash flow. The strategy focused on building infrastructure for durable, profitable growth while maintaining focus on student outcomes, culminating in 12 consecutive quarters of total enrollment growth.

    02

    "Purpose at Scale" Strategy Launch

    The company is now launching its next 3-year strategy, "Purpose at Scale," which carries forward operating discipline and adds three pillars: platform extension, employer integration, and technology. This strategy is underpinned by a structural demand backdrop in healthcare, with over 70% of clinicians and executives reporting staffing shortages affecting care quality. Covista aims to solve this problem by converting demand into qualified clinicians.

    03

    Platform Extension Initiatives

    Platform extension involves placing programs in more locations, formats, and markets. At Chamberlain, 6 new campuses are in active development, with 3 having full regulatory approval, and Cincinnati and Salt Lake scheduled to open in H1 FY27. Each campus requires $9 million to $12 million in capital, with an expected EBITDA breakeven within 24 months. Walden achieved its highest total enrollment ever, with broad-based growth across all degree levels, including undergraduate growth exceeding 20%, supported by new programs and persistence analytics.

    04

    Expanding Employer Partnerships

    Covista is expanding its employer partnerships, building on strong early results with SSM, which led to increased enrollment targets. A new collaboration with Advocate Health, the third-largest nonprofit integrated health system, will fund nursing education through Chamberlain. This program is expected to serve hundreds of students annually, creating a more durable enrollment model with lower acquisition costs, as employer commitment leads to higher enrollment rates and persistence.

    05

    Technology and AI Investments

    The company is investing in enterprise technology, having launched AI credentials with Google Cloud in Q3, adding 9 more certifications in Q4, and enrolling over 9,000 learners. Prototypes of an AI-powered classroom are currently being tested, with first live deployments expected in H2 FY27. Covista is adapting its marketing strategies for the shift from search optimization to AI answer optimization, leveraging trusted brands and strong student outcomes.

    06

    Leadership and Strategic Direction

    Covista strengthened its leadership with the addition of two new Board members, Emily Chiu and Leslie Storms, bringing relevant operating experience. Rick Sinkfield joined as VP of Expansion, overseeing campus growth, and Scott Liles became Chief Strategy and Performance Officer. The company emphasizes its strong foundation, proven operating model, and balance sheet to fund its growth plans, aiming to extend its leading position in healthcare workforce education and generate durable earnings.

    AI-generated summary of the company’s earnings call. Not investment advice.